metricas
covid
Medicina Clínica (English Edition) Erenumab for the treatment of chronic resistant migraine
Journal Information
Vol. 158. Issue 2.
Pages 96-97 (January 2022)
Vol. 158. Issue 2.
Pages 96-97 (January 2022)
Letter to the Editor
Erenumab for the treatment of chronic resistant migraine
Erenumab para el tratamiento de migraña crónica farmacorresistente
Almudena Layos-Romeroa,
Corresponding author
almudenalayos@gmail.com

Corresponding author.
, Alberto Andrés Lópezb, Laura Rojas Bartoloméc
a Servicio de Neurología, Hospital General Universitario de Albacete, Albacete, Spain
b Sección de Neurología, Hospital General de Almansa, Almansa, Spain
c Sección de Neurología, Hospital de Hellín, Hellín, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Results after three and six months of treatment.
Tables

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools